Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Saxenda is an injectable medication taken under the skin
The compound is frequently referred to as a triple-hormone-receptor agonist retatrutide because it simultaneously targets: GLP-1 receptor pathways Glucagon receptor pathways Glucose-dependent insulinotropic polypeptide receptor pathways This triple agonist mechanism differentiates retatrutide from earlier GLP-1 receptor agonist compounds and other research peptides currently studied for obesity and metabolic dysfunction
Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice
SS: Investigation, Methodology, Writing original draft, Software, Formal analysis, Data curation, Resources
US$ 21.65
US$ 23.97
US$ 28.61
